Search for:

In brief

As the 2019 Novel Coronavirus (COVID-19) continues to spread across the world, the challenges for companies operating in the healthcare and life sciences sector are increasing. Below is a list of some of the risks emerging and evolving for companies in this sector.

Read the checklist here.

Author

Dr. Isabella Liu is the head of the Firm's Asia Pacific Healthcare Industry Group. She advises clients on matters relating to the creation, exploitation and protection of IP rights. She is also responsible for the local IP Group’s China and Hong Kong patent prosecution matters. Dr. Liu is ranked as a leading lawyer in her field by top legal directories such as Chambers Asia Pacific for the Life Sciences category and IAM Patent. She has been complimented by clients that she possesses “a superb ability to understand the most complex technologies” and was noted for "advis[ing] in a way that is very commercial and strategic."